成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 56180-94-0 Chemical Structure| 56180-94-0
Chemical Structure| 56180-94-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 56180-94-0

,{[proInfo.pro_purity]}

Acarbose is an intestinal alpha-glucosidase inhibitor and can be used to treat type 2 diebetes.

Synonyms: BAY g 5421

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Acarbose

CAS No. :56180-94-0
Formula : C25H43NO18
M.W : 645.60
SMILES Code : O[C@H]1[C@]([H])(O[C@H]([C@@H]2O)O[C@@H]([C@H]([C@@H]2O)N[C@@]([H])(C=C3CO)[C@H](O)[C@H]([C@@H]3O)O)C)[C@@H](CO)O[C@@H]([C@@H]1O)O[C@@]([H])([C@@H]([C@H](C=O)O)O)[C@@H](CO)O
Synonyms :
BAY g 5421
MDL No. :MFCD00869592

Safety of Acarbose

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT00568074 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Shanghai ... More >> Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200025 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200433 China, Sichuan Novo Nordisk Investigational Site Chengdu, Sichuan, China, 610041 China Novo Nordisk Investigational Site Beijing, China, 100029 Less <<
NCT00000620 - Completed - -
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT01413035 Type 2 Diabetes Phase 1 Phase 2 Unknown July 2014 China, Shandong ... More >> Department of Hematology of the 2nd Hospital of Shandong University Recruiting Jinan, Shandong, China, 250033 Contact: chengyun zheng, Ph. D ?? +86-531-85875635 ?? chengyun.zheng@ki.se, kdx2002@126.com Less <<
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT00950534 Diabetes Mellitus, Type 2 Phase 4 Terminated(due to poor recruit... More >>ment) Less << - Australia ... More >> Sanofi-Aventis Administrative Office Macquarie Park, Australia Less <<
NCT03359837 Type 2 Diabetes Mellitus Phase 4 Recruiting November 7, 2019 China ... More >> Recruiting Not Listed, China Less <<
NCT00691314 Stroke Transi... More >>ent Ischemic Attack Atherosclerosis Stenosis Stents Less << Not Applicable Completed - China, Beijing ... More >> Beijing Tiantan Hospital Beijing, Beijing, China, 100050 Xuanwu Hospital Capital Medical University Beijing, Beijing, China, 100053 Peking Union Medical College Hospital Beijing, Beijing, China, 100730 China, Chongqing Southwest Hospital Chongqing, Chongqing, China, 400038 Daping Hospital Chongqing, Chongqing, China, 400042 China, Jiangsu Nanjing General Hospital of Nanjing Military Command Nanjing, Jiangsu, China, 210002 China, Jilin Jilin University Changchun, Jilin, China, 130021 China, Shanghai Huashan Hospital Fudan University Shanghai, Shanghai, China, 200040 China, Sichuan West China Center of Medical Sciences Chengdu, Sichuan, China, 610041 China, Tianjin The General Hospital Under Tianjin Medical Sciences University Tianjin, Tianjin, China, 300052 Less <<
NCT02273050 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Changchun, China Research Site Chuangchun, China Research Site Fuzhou, China Research Site Guiyang, China Research Site Ha'er bin, China Research Site Hangzhou, China Research Site Hefei, China Research Site Jinan, China Research Site Nanchang, China Research Site Nanjing, China Research Site Shanghai, China Research Site Shijiazhuang, China Research Site Siping, China Research Site Tianjin, China Research Site Wuxi, China Research Site Yueyang, China Less <<
NCT01697592 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00664846 Stroke Not Applicable Completed - -
NCT02527993 Hypoglycemia ... More >>Obesity Surgery Less << Phase 4 Completed - -
NCT01482494 - Unknown - Spain ... More >> Hospital Clínico de Barcelona Not yet recruiting Barcelona, Spain Less <<
NCT01512641 Dissociative Disorders ... More >> Schizophrenia Less << Not Applicable Completed - France ... More >> Psychiatrie infanto-juvénile - Centre Hospitalier d'Antibes Antibes, France, 06600 Psychiatrie infanto-juvénile-P?le femme-mère -enfant Fréjus, France, 83608 Service de psychiatrie de l'enfant et de l'adolescent Marseille, France, 13009 Service de psychiatrie de l'enfant et de l'adolescent Nice, France, 06000 Less <<
NCT02669693 Diabetes Not Applicable Completed - United Kingdom ... More >> School of Food Science and Nutrition, University of Leeds Leeds, West Yorkshire, United Kingdom, LS2 9JT Less <<
NCT02273050 - Completed - -
NCT00438698 Type 2 Diabetes ... More >> Cardiovascular Disease Less << Not Applicable Completed - Canada, Ontario ... More >> St. Michael's Hospital Toronto, Ontario, Canada, M5C 2T2 Less <<
NCT02527239 - Unknown September 2016 -
NCT01933490 Hyperinsulinemic Hypoglycemia Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00223691 Autonomic Failure ... More >> Orthostatic Hypotension Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02836704 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> China, China Less <<
NCT02072096 - Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT01242202 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01697592 - Completed - -
NCT02587741 Diabetic Retinopathy Early Phase 1 Recruiting July 2025 China, Guangdong ... More >> the third affiliated hospital of Sun yet-san university Recruiting Guangzhou, Guangdong, China, 510000 Contact: Zhu Bilian, master ?? +8613580364394 ?? bilianzhu@qq.com ?? Contact: Tang Xixiang, master ?? +8613570434387 ?? txx_8711@126.com Less <<
NCT00464594 Diabetes Mellitus Not Applicable Unknown - Japan ... More >> Tokyo Medical and Dental University Recruiting Tokyo, Japan, 113-8519 Contact ?? 03-3813-6111 Less <<
NCT00909051 - Completed - Algeria ... More >> Many Locations, Algeria Bosnia and Herzegovina Many Locations, Bosnia and Herzegovina Cambodia Many Locations, Cambodia China Many Locations, China Hong Kong Many Locations, Hong Kong India Many Locations, India Indonesia Many Locations, Indonesia Korea, Republic of Many Locations, Korea, Republic of Malaysia Many Locations, Malaysia Moldova, Republic of Many Locations, Moldova, Republic of Pakistan Many Locations, Pakistan Philippines Many Locations, Philippines Russian Federation Many Locations, Russian Federation Singapore Many Locations, Singapore Thailand Many Locations, Thailand Vietnam Many Locations, Vietnam Less <<
NCT01181674 Type 2 Diabetes Mellitus Phase 4 Completed - Canada, Ontario ... More >> McMaster University Medical Centre, Diabetes Care and Research Program Hamilton, Ontario, Canada, L8N 3Z5 Less <<
NCT02072096 Diabetes Mellitus, Type 2 Phase 4 Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT01514838 Type II Diabetes Mellitus Phase 3 Terminated(Discontinued due to... More >> company's strategic reason) Less << - Korea, Republic of ... More >> Busan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Seongnam, Korea, Republic of Seoul, Korea, Republic of Wonju, Korea, Republic of Taiwan Changha, Taiwan Chiayi, Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan, Taiwan Taipei, Taiwan Taoyuan, Taiwan Less <<
NCT02879955 Overweight Not Applicable Completed - Denmark ... More >> Dept. of Endocrinology Hvidovre, Denmark, 2650 Less <<
NCT02462369 Microalbuminuria ... More >> Microalbuminuria /Creatinine Ratios ACR Less << Phase 4 Unknown October 2017 -
NCT01685502 - Completed - Japan ... More >> Many Locations, Japan Less <<
NCT01219582 - Completed - India ... More >> Many Locations, India Less <<
NCT01612741 - Completed - India ... More >> Many Locations, India Less <<
NCT01624116 Diabetes, Type 2 Not Applicable Completed - Pakistan ... More >> Endocrinology Unit & Diabetes Management Centre, Services Hospital. Lahore, Pakistan Less <<
NCT01025765 Chronic Hepatitis C Phase 4 Unknown December 2012 Taiwan ... More >> National Taiwan University Hospital Department of Internal Medicine, Taipei, Taiwan, 10002 Less <<
NCT01388153 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> M?nchengladbach, Nordrhein-Westfalen, Germany, 41061 Less <<
NCT01019356 Polycystic Ovary Syndrome Not Applicable Active, not recruiting October 2021 Canada, Quebec ... More >> Université de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT02446834 Polycystic Ovary Syndrome Not Applicable Unknown August 2017 China, Shanghai ... More >> Renji Hospital Department of Endocrinology and Metabolism Recruiting Shanghai, Shanghai, China, 200127 Contact: Wei Liu, MD ?? +86-18918358342 ?? sue_liuwei@163.com ?? Contact: Jing Ma, MD ?? +86-15800983436 ?? cherry1996@live.cn Less <<
NCT00629213 Metabolic Syndrome Phase 3 Completed - Germany ... More >> GWT-TUD GmbH Dresden, Saxony, Germany, 01187 Less <<
NCT03241303 Glucose Metabolism Disorders Not Applicable Recruiting July 1, 2018 Denmark ... More >> Center for Diabetesresearch Recruiting Hellerup, Denmark, 2900 Contact: Filip K Knop, MD, PhD ?? 26830161 ?? Filipknop@dadlnet.dk Less <<
NCT01613105 - Completed - India ... More >> Many Locations, India Less <<
NCT01248481 - Completed - Korea, Republic of ... More >> Many Locations, Korea, Republic of Less <<
NCT02685852 Hyperinsulinemic Hypoglycemia Phase 2 Recruiting November 30, 2018 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Jayne Pederson Pederson ?? 612-624-8402 ?? peder059@umn.edu Less <<
NCT03383068 PCOS Impaired... More >> Glucose Tolerance Less << Phase 4 Not yet recruiting June 30, 2020 China, Shanghai ... More >> Renji Hospital Department of Endocrinology and Metabolism Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Wei Liu, MD ?? +86-18918358342 ?? sue_liuwei@163.com Less <<
NCT01863147 Newly Diagnosed Type 2 Diabete... More >>s Coronary Artery Disease Less << Phase 4 Completed - China, Hubei ... More >> Guangda Xiang Wuhan, Hubei, China, 430070 Wuhan General Hospital Wuhan, Hubei, China, 430070 Less <<
NCT00110240 Diabetes Mellitus, Type 2 Phase 3 Completed - Switzerland ... More >> Novartis Pharmaceuticals Basel, Switzerland Less <<
NCT03602638 Atherosclerosis Type 2 Diabete... More >>s Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 Less << Phase 4 Not yet recruiting December 1, 2020 -
NCT01915264 - Withdrawn March 2017 -
NCT00417950 Diabetes Mellitus|Impaired Glu... More >>cose Tolerance Less << UNKNOWN - Taichung Veterans General Hosp... More >>ital, Taichung, Taiwan Less <<
NCT01000688 Type 2 Diabetes ... More >> Endothelial Dysfunction Less << Phase 3 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT00970528 Diabetes Mellitus, Type 2 Phase 4 Completed - Korea, Republic of ... More >> Wonju-si, Gang''weondo, Korea, Republic of, 220-701 Busan, Korea, Korea, Republic of, 602-714 Gyeonggi-do, Korea, Korea, Republic of, 463-500 Gyeonggi-do, Korea, Korea, Republic of, 471-701 Pusan, Korea, Korea, Republic of, 602-739 Seoul, Korea, Korea, Republic of, 150-713 Daegu, Korea, Republic of, 705-717 Jeonju-si, Korea, Republic of, 456-712 Seongbuk-gu Seoul, Korea, Republic of, 136-705 Seoul, Korea, Republic of, 134-701 Seoul, Korea, Republic of, 135-710 Less <<
NCT01554631 Diabetes Mellitus, Type 2 Phase 1 Completed - Germany ... More >> M?nchengladbach, Nordrhein-Westfalen, Germany, 41061 Less <<
NCT00221156 Glucose Metabolism Disorders|C... More >>oronary Artery Disease Less << PHASE3 COMPLETED 2025-04-09 Institute of Biomedical Resear... More >>ch and Innovation., Kobe, Hyogo Pref., 650-0047, Japan|Kobe City General Hospital/Institute of Biomedical Research and Innovation, Kobe, Hyogo Pref., 650-0047, Japan|Kawasaki Medical School Hospital, Kurashiki, Okayama, 701-0192, Japan Less <<
NCT01709305 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02211950 Healthy Phase 1 Completed - -
NCT01175486 Diabetes Phase 4 Unknown December 2015 Taiwan ... More >> Taipei Veterans General Hospital, Taiwan Recruiting Taipei, Taiwan Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT01709305 - Completed - -
NCT00437918 Diabetes Mellitus ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - Korea, Republic of ... More >> Paik Diabetes Center, Pusan Paik Hospital, College of Medicine, Inje University Busan, Korea, Republic of, 614-735 Endocrinology and Metabolism, Maryknoll General Hospital Busan, Korea, Republic of Less <<
NCT02605772 Type 2 Diabetes Mellitus Phase 4 Unknown March 2017 -
NCT01758471 Type 2 Diabetes Phase 4 Unknown June 2014 China, Shanghai ... More >> Shanghai Clinic Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute for Endocrine and Metabolic Diseases Recruiting Shanghai, Shanghai, China, 200025 Contact: Guang Ning, M.D. ?? 86-021-64370045 ext 665344 Less <<
NCT00551954 Type 2 Diabetes Phase 3 Completed - -
NCT01198730 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 2019 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Wayne H-H Sheu, MD, PHD ?? ?? whhsheu@vghtc.gov.tw Less <<
NCT01030952 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> Sir Run Run Shaw Hospital, 3 East Qingchun Road Hangzhou, China, 310016 Shanghai Tongji Hospital, 389 Xinchun Road Shanghai, China, 200065 Shanghai Sixth People's Hospital, 600 Xuanshan Road Shanghai, China, 200233 Less <<
NCT01839344 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Washington ... More >> Bastyr Center for Natural Health Seattle, Washington, United States, 98103 Less <<
NCT01177384 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01030952 - Completed - -
NCT00928889 Diabetes Mellitus, Type 2 Phase 4 Completed - China ... More >> People's Liberation Army. The Military General Hospital of BeiJing BeiJing, China, 100020 Peiking University First Hospital BeiJing, China, 100034 Chinese PLA General Hospital Beijing, China, 100853 The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510080 The Second Affiliated Hospital, Zhongshan (Sun Yat-sen) University Guangzhou, China, 510120 Nanfang Hospital, the Affiliated South Hospital of the Southern Medical University Guangzhou, China, 510515 Less <<
NCT00677521 Non-alcoholic Fatty Liver Dise... More >>ase Less << PHASE2 TERMINATED 2025-08-08 The Hospital for Sick Children... More >>, Toronto, Ontario, Canada Less <<
NCT01177384 - Completed - -
NCT02589353 Healthy Volunteers PHASE4 COMPLETED 2023-02-16 Department of Food Science and... More >> Technology, Corvallis, Oregon, 97331, United States Less <<
NCT01010100 Diabetes Mellitus Phase 3 Completed - Spain ... More >> Agost, Alicante, Spain, 03698 Crevillente, Alicante, Spain Novelda, Alicante, Spain, 03660 San Vicente del Raspeig, Alicante, Spain, 03690 Terrassa, Barcelona, Spain, 08223 Trobajo del Camino, León, Spain, 24010 Begonte, Lugo, Spain, 27373 Villalba, Lugo, Spain, 27800 Camas, Sevilla, Spain, 41900 Constanti, Tarragona, Spain, 43120 Cornudella, Tarragona, Spain, 43360 El Morell, Tarragona, Spain, 43760 Falset, Tarragona, Spain, 43730 Les Borges del Camp, Tarragona, Spain, 43350 Reus, Tarragona, Spain, 43201 Reus, Tarragona, Spain, 43202 Reus, Tarragona, Spain, 43203 Tortosa, Tarragona, Spain, 43500 Vinebre, Tarragona, Spain, 43729 Alicante, Spain, 03007 Madrid, Spain, 28033 Tarragona, Spain, 43005 Tarragona, Spain, 43006 Less <<
NCT00928889 - Completed - -
NCT03344341 Type 2 Diabetes Mellitus Phase 4 Recruiting August 31, 2019 China ... More >> Research Site Not yet recruiting Beijing, China, 100020 Research Site Not yet recruiting Beijing, China, 100034 Research Site Not yet recruiting Beijing, China, 100730 Research Site Not yet recruiting Changsha, China, 410008 Research Site Not yet recruiting Changsha, China, 410011 Research Site Not yet recruiting Changsha, China, 410013 Research Site Not yet recruiting Chengdu, China, 610041 Research Site Not yet recruiting Chongqing, China, 400016 Research Site Not yet recruiting Guangzhou, China Research Site Not yet recruiting Guiyang, China Research Site Recruiting Hangzhou, China, 310014 Research Site Not yet recruiting Hangzhou, China, 310016 Research Site Not yet recruiting Hefei, China, 230022 Research Site Not yet recruiting Jinan, China, 250012 Research Site Not yet recruiting Kunming, China, 650032 Research Site Not yet recruiting Nanjing, China, 2100008 Research Site Not yet recruiting Nanjing, China, 210029 Research Site Not yet recruiting Qingdao, China, 266003 Research Site Not yet recruiting Qingdao, China Research Site Not yet recruiting Shanghai, China, 200032 Research Site Recruiting Shanghai, China, 200233 Research Site Recruiting Shanghai, China, CN-200120 Research Site Not yet recruiting Shenyang, China, 100003 Research Site Not yet recruiting Shenyang, China, 110001 Research Site Not yet recruiting Suzhou, China, 215004 Research Site Not yet recruiting Tianjin, China, CN-300070 Research Site Not yet recruiting Urumqi, China, 830054 Research Site Not yet recruiting Xi'an, China, 710061 Research Site Not yet recruiting Xining, China, 810001 Research Site Not yet recruiting Yinchuan, China, 750004 Less <<
NCT02438397 Type 2 Diabetes Phase 4 Unknown October 2016 China, Shanghai ... More >> the 6th affliliated hospital of Shanghai Jiaotong university Recruiting Shanghai, Shanghai, China, 200233 Less <<
NCT01244971 Diabetes Mellitus Type 2 Phase 4 Completed - Sweden ... More >> Enheten f?r Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital Stockholm, Sweden, 17176 Less <<
NCT00558883 Type 2 Diabetes Mellitus ... More >> Subclinical Inflammation Less << Phase 3 Completed - Germany ... More >> GWT-TUD GmbH; Centre for Clinical Studies Dresden, Germany, 01187 Less <<
NCT00846521 Pediatric Obesity|Insulin Resi... More >>stance|Impaired Glucose Tolerance|Cardiovascular Disease Less << PHASE4 TERMINATED 2025-09-08 Yale School of Medicine, New H... More >>aven, Connecticut, 06511, United States Less <<
NCT01333774 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT02315495 Type 2 Diabetes Phase 3 Completed - China, Jiangsu ... More >> Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Less <<
NCT00829660 Coronary Heart Disease ... More >> Acute Coronary Syndrome Impaired Glucose Tolerance Type 2 Diabetes Mellitus (T2DM) Less << Phase 4 Completed - -
NCT01961388 - Withdrawn June 2017 -
NCT00846521 Pediatric Obesity|Insulin Resi... More >>stance|Impaired Glucose Tolerance|Cardiovascular Disease Less << PHASE4 TERMINATED 2025-09-08 Yale School of Medicine, New H... More >>aven, Connecticut, 06511, United States Less <<
NCT01470937 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Indiana ... More >> Indiana University Hospital GCRC Indianapolis, Indiana, United States, 46202 Less <<
NCT01316861 Type 2 Diabetes Mellitus Phase 3 Completed - Brazil ... More >> Marcio Antonio Pereira Clinica Sao Jose Dos Campos, SP, Brazil, 12.245-000 Less <<
NCT00417729 Diabetes Mellitus PHASE4 COMPLETED 2025-01-09 Taichung Veterans General Hosp... More >>ital, Taichung, Taiwan Less <<
NCT00858676 Diabetes Mellitus ... More >> Impaired Glucose Tolerance Coronary Artery Disease Less << Phase 4 Unknown March 2013 Japan ... More >> Dept. of Intern. Med., School of Dentistry, Aichi Gakuin University Recruiting Nagoya, Japan, 464-8650 Contact: Tatsuaki Matsubara, MD, PhD ?? +81-52-759-2111 ?? ?? Principal Investigator: Tatsuaki Matsubara, MD, PhD Less <<
NCT01245166 The Objectives of the Study is... More >> to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in Subjects With Type 2 Diabetes Mellitus. Less << Phase 3 Unknown December 2011 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Elaine Liu, Bachelor ?? 886-2-2778-5188 ext 335 ?? elaine@lotuspharm.com Less <<
NCT03349684 Diabetes Mellitus, Type 2 Phase 3 Recruiting September 11, 2019 -
NCT01728740 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Seoul, Korea, Republic of, 110-744 Less <<
NCT01490918 Type-II Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> MedicalExcellence Seoul, Korea, Republic of, 137-701 Less <<
NCT02143765 Type 2 Diabetes Mellitus Phase 4 Completed - China, Jiangsu ... More >> The First People's Hospital of Changzhou Changzhou, Jiangsu, China The Second People's Hospital of Huai'an Huai'an, Jiangsu, China Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Xuzhou Central Hospital Xuzhou, Jiangsu, China Yancheng City No.1 People's Hospital Yancheng, Jiangsu, China Zhenjiang First People's Hospital Zhenjiang, Jiangsu, China Less <<
NCT02049814 Type 2 Diabetes Mellitus Phase 4 Completed - China, Anhui ... More >> Hefei, Anhui, China Maanshan, Anhui, China China, Beijing Beijing, Beijing, China China, Guangdong Guangzhou, Guangdong, China Shenzhen, Guangdong, China Taishan, Guangdong, China China, Hunan Zhuzhou, Hunan, China China, Jiangsu Nanjing, Jiangsu, China Xuzhou, Jiangsu, China China, Jilin Changchun, Jilin, China Jilin, Jilin, China China, Liaoning Shenyang, Liaoning, China China, Shandong Qingdao, Shandong, China China, Shanghai Shanghai, Shanghai, China China, Shanxi Yan An, Shanxi, China Yanan, Shanxi, China China, Tianjin Tianjin, Tianjin, China China, Zhejiang Wenzhou, Zhejiang, China Less <<
NCT02999841 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Phase 4 Unknown January 2018 China, Beijing ... More >> Beijing Pinggu Hospital Recruiting Beijing, Beijing, China, 101200 Contact: Yufeng Li, MD ?? +86 139 1108 0328 ?? ?? Principal Investigator: Yufeng Li, MD Less <<
NCT03380546 Gestational Diabetes Mellitus ... More >>in Pregnancy Less << Phase 3 Recruiting March 30, 2022 France ... More >> Jean Verdier Hospital Recruiting Bondy, France, 93140 Contact: Emmanuel COSSON, MD-PhD ?? 01 48 02 65 94 ext +33 ?? emmanuel.cosson@aphp.fr Less <<
NCT02243176 - Completed - -
NCT01167231 - Completed - Poland ... More >> Many Locations, Poland Less <<
NCT02243176 Type 2 Diabetes Mellitus Phase 4 Completed - China ... More >> Research Site Shanghai, China Less <<
NCT01279512 PCO Phase 4 Completed - Iran, Islamic Republic of ... More >> Royan Institute Tehran, Iran, Islamic Republic of Less <<
NCT02500329 Endothelial Function ... More >> Type 2 Diabetes Gemigliptin Acarbose Less << Phase 4 Unknown - Korea, Republic of ... More >> Boramae medical center Recruiting Seoul, Korea, Republic of, 156-707 Contact: Bokyung Koo ?? ?? bokyungkoomd@gmail.com ?? Principal Investigator: Min Kyong Moon Less <<
NCT02865499 Aging Phase 2 Completed - United States, Texas ... More >> UTHSCSA San Antonio, Texas, United States, 78220 Less <<
NCT02043886 Type 2 Diabetes ... More >> Postprandial Hypotension Less << Phase 2 Completed - Canada, British Columbia ... More >> VITALiTY Research Centre Vancouver, British Columbia, Canada, V5Z1M9 Less <<
NCT02355509 Glucose Intolerance ... More >> Postprandial Hyperglycemia Cardiovascular Risk Factor Less << Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán México City, Distrito Federal, Mexico, 14000 Less <<
NCT02953093 Aging Phase 2 Recruiting April 2019 United States, New York ... More >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10461 Contact: Erika F Brutsaert, MD, MPH ?? 866-633-8255 ?? ?? Principal Investigator: Erika F Brutsaert, MD, MPH Less <<
NCT01914133 Other Specified Hypotension ... More >> Syncope Less << Phase 2 Recruiting August 2018 Canada, British Columbia ... More >> Vancouver Coastal Health Research Institute, VGH Research Pavilion Room 186 Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman ?? 604-875-5115 ?? boris.feldman@vch.ca ?? Principal Investigator: Kenneth M Madden, MD MSc FRCPC ?? ?? ?? Sub-Investigator: Graydon Meneilly, MD, FRCPC Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.55mL

0.31mL

0.15mL

7.74mL

1.55mL

0.77mL

15.49mL

3.10mL

1.55mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories